Concepts (282)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlear Implantation | 18 | 2025 | 52 | 6.120 |
Why?
|
| Cochlear Implants | 13 | 2025 | 59 | 4.200 |
Why?
|
| Neuroma, Acoustic | 9 | 2024 | 32 | 2.770 |
Why?
|
| Hearing Loss, Sensorineural | 8 | 2025 | 157 | 2.470 |
Why?
|
| Cholesteatoma, Middle Ear | 5 | 2024 | 13 | 2.450 |
Why?
|
| Temporal Bone | 8 | 2021 | 38 | 1.980 |
Why?
|
| Otologic Surgical Procedures | 7 | 2023 | 25 | 1.920 |
Why?
|
| Mastoid | 5 | 2024 | 25 | 1.430 |
Why?
|
| Hearing Loss | 5 | 2024 | 214 | 1.390 |
Why?
|
| Tympanic Membrane | 2 | 2021 | 19 | 1.230 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 2 | 2021 | 5 | 1.210 |
Why?
|
| Encephalocele | 4 | 2020 | 48 | 1.200 |
Why?
|
| Fistula | 3 | 2021 | 53 | 1.170 |
Why?
|
| Speech Perception | 5 | 2025 | 57 | 1.100 |
Why?
|
| Mastoidectomy | 2 | 2024 | 6 | 1.100 |
Why?
|
| Granuloma | 2 | 2016 | 68 | 0.960 |
Why?
|
| Cerebellopontine Angle | 1 | 2025 | 8 | 0.940 |
Why?
|
| Ear Canal | 2 | 2023 | 10 | 0.940 |
Why?
|
| Lipoma | 1 | 2025 | 26 | 0.930 |
Why?
|
| Cholesterol | 3 | 2016 | 573 | 0.900 |
Why?
|
| Skull Base | 3 | 2021 | 52 | 0.870 |
Why?
|
| Cholesteatoma | 1 | 2023 | 6 | 0.820 |
Why?
|
| Cranial Sinuses | 2 | 2022 | 12 | 0.800 |
Why?
|
| Neonatal Screening | 1 | 2024 | 193 | 0.800 |
Why?
|
| Retrospective Studies | 32 | 2025 | 17423 | 0.780 |
Why?
|
| Cytomegalovirus Infections | 1 | 2024 | 229 | 0.780 |
Why?
|
| Ear, Middle | 4 | 2020 | 26 | 0.770 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2025 | 3843 | 0.750 |
Why?
|
| Tympanoplasty | 2 | 2024 | 11 | 0.740 |
Why?
|
| Ear Neoplasms | 3 | 2018 | 14 | 0.730 |
Why?
|
| Hemangioma, Capillary | 1 | 2021 | 17 | 0.720 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2021 | 2173 | 0.720 |
Why?
|
| Craniotomy | 3 | 2017 | 106 | 0.700 |
Why?
|
| Ear, Inner | 1 | 2021 | 50 | 0.700 |
Why?
|
| Adult | 40 | 2025 | 31880 | 0.700 |
Why?
|
| Cerebellar Neoplasms | 1 | 2025 | 460 | 0.680 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2020 | 17 | 0.670 |
Why?
|
| Skull Neoplasms | 2 | 2017 | 16 | 0.660 |
Why?
|
| Deafness | 1 | 2020 | 86 | 0.630 |
Why?
|
| Petrous Bone | 2 | 2015 | 5 | 0.630 |
Why?
|
| Quality of Life | 3 | 2024 | 2150 | 0.620 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 2 | 2015 | 11 | 0.610 |
Why?
|
| Labyrinth Diseases | 1 | 2018 | 6 | 0.610 |
Why?
|
| Humans | 72 | 2025 | 133736 | 0.600 |
Why?
|
| Female | 48 | 2025 | 71617 | 0.600 |
Why?
|
| Middle Aged | 33 | 2025 | 29298 | 0.600 |
Why?
|
| Semicircular Canals | 1 | 2018 | 20 | 0.600 |
Why?
|
| Electrodes, Implanted | 2 | 2016 | 169 | 0.590 |
Why?
|
| Male | 46 | 2025 | 65867 | 0.580 |
Why?
|
| Neurotology | 1 | 2018 | 2 | 0.580 |
Why?
|
| Plasmacytoma | 1 | 2017 | 9 | 0.540 |
Why?
|
| Aged | 27 | 2025 | 21680 | 0.530 |
Why?
|
| Postoperative Complications | 7 | 2023 | 3167 | 0.530 |
Why?
|
| Facial Nerve | 4 | 2023 | 26 | 0.520 |
Why?
|
| Child | 20 | 2025 | 25768 | 0.520 |
Why?
|
| Iatrogenic Disease | 2 | 2020 | 132 | 0.520 |
Why?
|
| Marital Status | 1 | 2016 | 32 | 0.520 |
Why?
|
| Tinnitus | 3 | 2022 | 23 | 0.520 |
Why?
|
| Scala Tympani | 1 | 2016 | 3 | 0.510 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 300 | 0.500 |
Why?
|
| Cranial Fossa, Middle | 1 | 2015 | 1 | 0.490 |
Why?
|
| Vestibule, Labyrinth | 3 | 2023 | 44 | 0.480 |
Why?
|
| Glomus Tympanicum Tumor | 1 | 2015 | 1 | 0.470 |
Why?
|
| Surgical Mesh | 1 | 2015 | 70 | 0.470 |
Why?
|
| Temporal Lobe | 1 | 2015 | 118 | 0.460 |
Why?
|
| Prednisone | 1 | 2015 | 288 | 0.460 |
Why?
|
| Treatment Outcome | 16 | 2024 | 13005 | 0.450 |
Why?
|
| Fascia | 1 | 2014 | 16 | 0.450 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2015 | 91 | 0.440 |
Why?
|
| Adolescent | 16 | 2025 | 20525 | 0.420 |
Why?
|
| Pancreatic Neoplasms | 2 | 2010 | 732 | 0.410 |
Why?
|
| Perioperative Care | 1 | 2015 | 219 | 0.410 |
Why?
|
| Suture Techniques | 1 | 2014 | 187 | 0.410 |
Why?
|
| Facial Paralysis | 2 | 2023 | 34 | 0.400 |
Why?
|
| Glucocorticoids | 1 | 2015 | 402 | 0.390 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2015 | 219 | 0.390 |
Why?
|
| Young Adult | 13 | 2025 | 9874 | 0.370 |
Why?
|
| Hearing | 4 | 2023 | 62 | 0.370 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 770 | 0.360 |
Why?
|
| Pancreatectomy | 2 | 2010 | 151 | 0.360 |
Why?
|
| Glomus Jugulare Tumor | 3 | 2016 | 5 | 0.360 |
Why?
|
| Vestibular Diseases | 2 | 2023 | 68 | 0.360 |
Why?
|
| Stapes Surgery | 2 | 2021 | 4 | 0.360 |
Why?
|
| Otolaryngologists | 2 | 2020 | 9 | 0.350 |
Why?
|
| Reoperation | 4 | 2025 | 852 | 0.340 |
Why?
|
| Headache | 2 | 2025 | 110 | 0.340 |
Why?
|
| Carcinoma, Lobular | 1 | 2010 | 26 | 0.330 |
Why?
|
| Seizures | 1 | 2015 | 889 | 0.330 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2010 | 253 | 0.330 |
Why?
|
| Child, Preschool | 11 | 2025 | 14806 | 0.330 |
Why?
|
| Otolaryngology | 2 | 2020 | 109 | 0.300 |
Why?
|
| Burnout, Professional | 2 | 2020 | 130 | 0.290 |
Why?
|
| Radiosurgery | 4 | 2018 | 147 | 0.290 |
Why?
|
| Kidney Neoplasms | 2 | 2010 | 461 | 0.280 |
Why?
|
| Prosthesis Failure | 2 | 2025 | 162 | 0.270 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 7196 | 0.260 |
Why?
|
| Auditory Threshold | 2 | 2016 | 17 | 0.250 |
Why?
|
| Head and Neck Neoplasms | 3 | 2019 | 701 | 0.240 |
Why?
|
| Paraganglioma | 2 | 2014 | 25 | 0.230 |
Why?
|
| Vestibular Function Tests | 2 | 2023 | 34 | 0.230 |
Why?
|
| Equipment Failure | 1 | 2025 | 133 | 0.230 |
Why?
|
| Operative Time | 2 | 2016 | 184 | 0.220 |
Why?
|
| Multilingualism | 1 | 2024 | 43 | 0.220 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 1 | 2023 | 11 | 0.210 |
Why?
|
| Mass Screening | 2 | 2021 | 836 | 0.210 |
Why?
|
| Cautery | 1 | 2023 | 6 | 0.210 |
Why?
|
| Electrocoagulation | 1 | 2023 | 33 | 0.200 |
Why?
|
| Endoscopy | 3 | 2016 | 287 | 0.200 |
Why?
|
| Incus | 1 | 2021 | 1 | 0.190 |
Why?
|
| Bell Palsy | 1 | 2021 | 6 | 0.190 |
Why?
|
| Earache | 1 | 2021 | 3 | 0.180 |
Why?
|
| Stapedius | 1 | 2021 | 1 | 0.180 |
Why?
|
| Hearing Loss, Conductive | 1 | 2021 | 16 | 0.180 |
Why?
|
| Tendons | 1 | 2021 | 40 | 0.180 |
Why?
|
| Otosclerosis | 1 | 2021 | 4 | 0.180 |
Why?
|
| United States | 4 | 2024 | 11711 | 0.180 |
Why?
|
| Audiometry | 2 | 2018 | 23 | 0.180 |
Why?
|
| Differential Threshold | 1 | 2020 | 11 | 0.170 |
Why?
|
| Labyrinthitis | 1 | 2020 | 10 | 0.170 |
Why?
|
| Surveys and Questionnaires | 3 | 2021 | 3992 | 0.170 |
Why?
|
| Facial Nerve Diseases | 2 | 2021 | 6 | 0.170 |
Why?
|
| Cohort Studies | 4 | 2023 | 5195 | 0.170 |
Why?
|
| Breast Neoplasms | 2 | 2010 | 2767 | 0.170 |
Why?
|
| Auditory Cortex | 1 | 2020 | 28 | 0.170 |
Why?
|
| Physical Examination | 1 | 2021 | 164 | 0.160 |
Why?
|
| Hydrocephalus | 1 | 2023 | 276 | 0.160 |
Why?
|
| Meningioma | 1 | 2022 | 143 | 0.160 |
Why?
|
| Skull Base Neoplasms | 1 | 2019 | 42 | 0.160 |
Why?
|
| Brain Stem | 1 | 2020 | 121 | 0.160 |
Why?
|
| Meningeal Neoplasms | 1 | 2022 | 217 | 0.160 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 1974 | 0.150 |
Why?
|
| Vestibulocochlear Nerve | 1 | 2018 | 5 | 0.150 |
Why?
|
| SEER Program | 2 | 2016 | 224 | 0.150 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 1 | 2018 | 15 | 0.140 |
Why?
|
| Neurilemmoma | 1 | 2018 | 48 | 0.140 |
Why?
|
| Neuroendocrine Tumors | 1 | 2018 | 55 | 0.140 |
Why?
|
| Postoperative Period | 2 | 2016 | 343 | 0.140 |
Why?
|
| Paranasal Sinus Neoplasms | 2 | 2015 | 18 | 0.140 |
Why?
|
| Otitis Media | 2 | 2014 | 86 | 0.140 |
Why?
|
| Adenoma | 1 | 2018 | 143 | 0.130 |
Why?
|
| Acoustic Impedance Tests | 1 | 2016 | 7 | 0.130 |
Why?
|
| Electric Impedance | 1 | 2016 | 68 | 0.130 |
Why?
|
| Audiology | 1 | 2016 | 6 | 0.130 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2015 | 8 | 0.120 |
Why?
|
| Ticlopidine | 1 | 2015 | 30 | 0.120 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2015 | 25 | 0.120 |
Why?
|
| Eustachian Tube | 1 | 2015 | 5 | 0.120 |
Why?
|
| Dizziness | 1 | 2015 | 29 | 0.120 |
Why?
|
| Neurosurgical Procedures | 2 | 2018 | 317 | 0.120 |
Why?
|
| Bone Plates | 1 | 2015 | 26 | 0.120 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 3743 | 0.120 |
Why?
|
| Meningocele | 1 | 2015 | 18 | 0.120 |
Why?
|
| Papilloma, Inverted | 1 | 2015 | 2 | 0.120 |
Why?
|
| Sex Distribution | 1 | 2016 | 331 | 0.120 |
Why?
|
| Age Distribution | 1 | 2016 | 444 | 0.120 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2015 | 24 | 0.120 |
Why?
|
| Glomus Tympanicum | 1 | 2014 | 2 | 0.120 |
Why?
|
| Glomus Jugulare | 1 | 2014 | 1 | 0.120 |
Why?
|
| Meningitis | 1 | 2015 | 101 | 0.120 |
Why?
|
| Cranial Nerve Diseases | 1 | 2015 | 27 | 0.120 |
Why?
|
| Ear Diseases | 1 | 2015 | 21 | 0.120 |
Why?
|
| Skull Fractures | 1 | 2015 | 43 | 0.120 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2014 | 8 | 0.110 |
Why?
|
| Meningitis, Pneumococcal | 1 | 2014 | 41 | 0.110 |
Why?
|
| Warfarin | 1 | 2015 | 125 | 0.110 |
Why?
|
| Autografts | 1 | 2014 | 29 | 0.110 |
Why?
|
| Age of Onset | 1 | 2016 | 636 | 0.110 |
Why?
|
| Foreign-Body Migration | 1 | 2015 | 61 | 0.110 |
Why?
|
| Polyps | 1 | 2015 | 44 | 0.110 |
Why?
|
| Aspirin | 1 | 2015 | 231 | 0.110 |
Why?
|
| Adenocarcinoma | 2 | 2014 | 1070 | 0.110 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2015 | 284 | 0.100 |
Why?
|
| Prognosis | 4 | 2018 | 5073 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2016 | 505 | 0.100 |
Why?
|
| Pneumococcal Vaccines | 1 | 2014 | 172 | 0.100 |
Why?
|
| Surgical Flaps | 1 | 2015 | 196 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2016 | 1338 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2022 | 1313 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 2165 | 0.100 |
Why?
|
| Hemorrhage | 1 | 2015 | 507 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 1407 | 0.090 |
Why?
|
| Risk Assessment | 3 | 2016 | 3711 | 0.090 |
Why?
|
| Infant, Newborn | 1 | 2024 | 8589 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2016 | 5468 | 0.090 |
Why?
|
| Genetic Testing | 2 | 2015 | 1094 | 0.090 |
Why?
|
| Disease Management | 1 | 2015 | 564 | 0.090 |
Why?
|
| Research Design | 1 | 2015 | 747 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2023 | 3031 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2015 | 603 | 0.090 |
Why?
|
| Psychological Tests | 2 | 2020 | 94 | 0.080 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2010 | 93 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2014 | 1596 | 0.080 |
Why?
|
| Keratotomy, Radial | 1 | 2009 | 31 | 0.080 |
Why?
|
| Infant | 4 | 2024 | 13174 | 0.080 |
Why?
|
| Mitomycin | 1 | 2009 | 52 | 0.080 |
Why?
|
| Photorefractive Keratectomy | 1 | 2009 | 69 | 0.080 |
Why?
|
| Hyperopia | 1 | 2009 | 59 | 0.080 |
Why?
|
| Vaccination | 1 | 2014 | 1013 | 0.080 |
Why?
|
| Lung Neoplasms | 2 | 2010 | 1782 | 0.080 |
Why?
|
| Myopia | 1 | 2009 | 132 | 0.070 |
Why?
|
| Incidence | 1 | 2016 | 3402 | 0.070 |
Why?
|
| Cochlea | 2 | 2020 | 90 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3650 | 0.070 |
Why?
|
| Self Report | 2 | 2020 | 553 | 0.070 |
Why?
|
| Visual Acuity | 1 | 2009 | 707 | 0.060 |
Why?
|
| Child Language | 1 | 2024 | 33 | 0.060 |
Why?
|
| Phonetics | 1 | 2024 | 45 | 0.060 |
Why?
|
| Speech | 1 | 2024 | 77 | 0.050 |
Why?
|
| Caloric Tests | 1 | 2023 | 7 | 0.050 |
Why?
|
| Schwann Cells | 1 | 2024 | 68 | 0.050 |
Why?
|
| Vertigo | 1 | 2023 | 35 | 0.050 |
Why?
|
| Prevalence | 2 | 2020 | 2667 | 0.050 |
Why?
|
| Ecosystem | 1 | 2024 | 110 | 0.050 |
Why?
|
| Arachnoid | 1 | 2022 | 9 | 0.050 |
Why?
|
| Algorithms | 2 | 2022 | 1733 | 0.050 |
Why?
|
| Language | 1 | 2024 | 220 | 0.050 |
Why?
|
| Head | 1 | 2023 | 113 | 0.050 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2023 | 58 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 1388 | 0.050 |
Why?
|
| Decision Trees | 1 | 2022 | 51 | 0.050 |
Why?
|
| Face | 1 | 2023 | 189 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2014 | 669 | 0.050 |
Why?
|
| Chorda Tympani Nerve | 1 | 2021 | 2 | 0.050 |
Why?
|
| Round Window, Ear | 1 | 2021 | 2 | 0.050 |
Why?
|
| Ligaments | 1 | 2021 | 21 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2022 | 239 | 0.050 |
Why?
|
| Prolapse | 1 | 2021 | 10 | 0.050 |
Why?
|
| Bone Conduction | 1 | 2021 | 7 | 0.050 |
Why?
|
| Intraoperative Period | 1 | 2021 | 74 | 0.050 |
Why?
|
| Vital Signs | 1 | 2021 | 22 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 356 | 0.040 |
Why?
|
| Internship and Residency | 2 | 2020 | 1251 | 0.040 |
Why?
|
| Plasma Cells | 1 | 2019 | 57 | 0.040 |
Why?
|
| Urban Population | 1 | 2021 | 240 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 690 | 0.040 |
Why?
|
| Caregivers | 1 | 2024 | 586 | 0.040 |
Why?
|
| Vestibulocochlear Nerve Injuries | 1 | 2018 | 1 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2022 | 920 | 0.040 |
Why?
|
| Machine Learning | 1 | 2022 | 335 | 0.040 |
Why?
|
| Facial Nerve Injuries | 1 | 2018 | 7 | 0.040 |
Why?
|
| Neoplasm, Residual | 1 | 2018 | 134 | 0.040 |
Why?
|
| Gadolinium | 1 | 2018 | 117 | 0.030 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2018 | 91 | 0.030 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2017 | 45 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 479 | 0.030 |
Why?
|
| Sutures | 1 | 2017 | 66 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 824 | 0.030 |
Why?
|
| Stents | 1 | 2022 | 877 | 0.030 |
Why?
|
| Cadaver | 1 | 2016 | 138 | 0.030 |
Why?
|
| Remission, Spontaneous | 1 | 2015 | 69 | 0.030 |
Why?
|
| Hearing Tests | 1 | 2015 | 16 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 2297 | 0.030 |
Why?
|
| Watchful Waiting | 1 | 2015 | 78 | 0.030 |
Why?
|
| Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2014 | 25 | 0.030 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2015 | 72 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2015 | 158 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2015 | 197 | 0.030 |
Why?
|
| Microsurgery | 1 | 2015 | 65 | 0.030 |
Why?
|
| Immunization Schedule | 1 | 2014 | 105 | 0.030 |
Why?
|
| Vaccines, Conjugate | 1 | 2014 | 83 | 0.030 |
Why?
|
| Ethmoid Sinus | 1 | 2014 | 9 | 0.030 |
Why?
|
| Nose Neoplasms | 1 | 2014 | 34 | 0.030 |
Why?
|
| Radiography | 1 | 2016 | 825 | 0.030 |
Why?
|
| Orbit | 1 | 2014 | 88 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2014 | 195 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 333 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 972 | 0.020 |
Why?
|
| Hypertension | 1 | 2021 | 1397 | 0.020 |
Why?
|
| Disease Progression | 1 | 2018 | 2239 | 0.020 |
Why?
|
| Acute Disease | 1 | 2014 | 1191 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2024 | 4907 | 0.020 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2010 | 57 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 1255 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2014 | 1242 | 0.020 |
Why?
|
| Corneal Topography | 1 | 2009 | 154 | 0.020 |
Why?
|
| Robotics | 1 | 2010 | 109 | 0.020 |
Why?
|
| Laryngoscopy | 1 | 2010 | 157 | 0.020 |
Why?
|
| Obesity | 1 | 2020 | 2433 | 0.020 |
Why?
|
| Refraction, Ocular | 1 | 2009 | 217 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 1309 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 6585 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 11114 | 0.010 |
Why?
|